Award

Synthetic design and directed evolution of disaggregating chaperones to detoxify disease-causing aggregates

Description: In aging mammals, various protein aggregates can cause tissue degeneration, as in Huntington’s and Parkinson’s diseases. To maintain protein homeostasis, all organisms house a network of molecular chaperones that can effectively, at least in youth, maintain levels of harmful protein conformers below their toxicity threshold. Many chaperones can use ATP to forcefully unfold toxic aggregates and convert them into harmless functional or degraded proteins. Whereas in young mammals, the disaggregating chaperones are highly effective, for unclear reasons, they gradually fail beyond reproduction age, unleashing toxic protein aggregations, cell death and tissue degeneration. The general aim of this research is to use methods of molecular biology, biochemistry, directed molecular evolution and of synthetic biology, to increase our knowledge of the mechanisms by which two distinct known disaggregating chaperone machineries, which co-exist in yeast but not in humans, can recognize harmful aggregates and convert them into harmless products. Both are composed of an HSP70 core acting as an ATP-fuelled polypeptide-unfolding nanomachine. In the first, HSP70 (SSA1, yeast chaperones in parentheses) activates an unrelated ring-shaped complex belonging to the AAA+ family (HSP104), which can forcefully thread within its central cavity, entangled polypeptide loops protruding from aggregates. In the second, HSP70 closely collaborates with a cognate called HSP110 (SSE1) and with a DNAJ co-chaperone (SIS1). Despite clear sequence and structure homologies, HSP110 is still generally thought to serve as a mere nucleotide exchange factor of it HSP70 relative, while lacking chaperone activity of its own. How, assisted by DNAJ, may the HSP70s and HSP110s precisely identify, bind and use ATP to unfold their stably aggregated substrates, remains unclear and is a matter of debate.
Amount: CHF 572,000
Funding type: research
Funder scheme: Project funding
Start date: 2018-11-01
End date: 2022-07-31
Institutions: University of Lausanne, University of Lausanne – LA
Funded outputs count: 8
Funder award ID: 175453
OpenAlex ID: G6575384199
2025 · Mathieu E. Rebeaud, Bruno Fauvet, et al. · Journal of Biological Chemistry · 6
2024 · Mathieu E. Rebeaud, Satyam Tiwari, et al. · Cell Stress and Chaperones · 7
2023 · Anthony Guihur, Baptiste Bourgine, et al. · Plant Methods · 1
2022 · Hadar Manis Levy, Avi Schneider, et al. · Physical Chemistry Chemical Physics · 12
2022 · Anthony Guihur, Mathieu E. Rebeaud, et al. · Trends in Biochemical Sciences · 173
2022 · Oran Melanker, Pierre Goloubinoff, et al. · Journal of Molecular Biology
2022 · Anthony Guihur, Mathieu E. Rebeaud, et al. · Trends in Plant Science · 39